Key attributes make Sanger sequencing and fragment analysis via capillary electrophoresis (CE) a foundational application in a range of clinical environments from clinical research, hospital-associated laboratories running molecular assays to larger reference laboratories performing approved in vitro diagnostic assays.
Highly accurate: proven technology with reliable results
Simple workflow: rapid time to results
Application flexibility: address large number of assays
Cost effective: more answers from limited budget
Dedicated service and support: keep your lab up and running
From spinal muscular atrophy (SMA) and Duchenne Muscular Dystrophy (DMD) to microsatellite instability (MSI) testing, Sanger sequencing and fragment analysis are driving critical clinical research and testing.
Learn how incorporating fragment analysis could better manage postoperative pain control
Perform your clinical research and molecular assays using the Applied Biosystems’ Sanger sequencing and fragment analysis workflows. From reagents, kits and consumables to software, instruments and service teams, we have what you need to keep your lab up and running.
Research and clinical products available. Please refer to intended use statements of individual products.